High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia
Permalink
Citation
Karimi , M , Nilsson , C , Dimitriou , M , Jansson , M , Matsson , H , Unneberg , P , Lehmann , S , Kere , J & Hellstrom-Lindberg , E 2015 , ' High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia ' , Haematologica , vol. 100 , no. 6 , pp. E223-E225 . https://doi.org/10.3324/haematol.2014.118034
| Title: | High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia |
| Author: | Karimi, Mohsen; Nilsson, Christer; Dimitriou, Marios; Jansson, Monika; Matsson, Hans; Unneberg, Per; Lehmann, Soren; Kere, Juha; Hellstrom-Lindberg, Eva |
| Contributor organization: | Research Programs Unit Juha Kere / Principal Investigator Research Programme for Molecular Neurology Medicum |
| Date: | 2015-06 |
| Language: | eng |
| Number of pages: | 3 |
| Belongs to series: | Haematologica |
| ISSN: | 0390-6078 |
| DOI: | https://doi.org/10.3324/haematol.2014.118034 |
| URI: | http://hdl.handle.net/10138/162089 |
| Subject: |
myelodysplastic syndromes
acute myeloid leukemia secondary therapy-related high-throughput mutational screening ADULTS RECOMMENDATIONS EUROPEAN LEUKEMIANET DIAGNOSIS 3121 General medicine, internal medicine and other clinical medicine |
| Peer reviewed: | No |
| Rights: | cc_by |
| Usage restriction: | openAccess |
| Self-archived version: | publishedVersion |
Files in this item
Total number of downloads: Loading...
| Files | Size | Format | View |
|---|---|---|---|
| 100e223.pdf | 555.8Kb |
View/ |
This item appears in the following Collection(s)
-
Articles from TUHAT system
[53264]